-+ 0.00%
-+ 0.00%
-+ 0.00%

Barrington Research Maintains Outperform on US Physical Therapy, Lowers Price Target to $98

Benzinga·02/28/2025 12:46:56
Listen to the news
Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and lowers the price target from $108 to $98.